Mouse and Caenorhabditis elegans mutants with altered lifespans are being used to investigate the aging process and how genes determine lifespan.
INTRODUCTION
The aging process can be studied by investigating genetic variants that alter lifespan in model organisms (Finch and Ruvkun 2001; Hekimi 2006) . For example, the fact that mutations of genes involved in the insulin/insulin-like signalling pathway can extend lifespan in Caenorhabditis elegans, Drosophila and mice is considered to imply a role for this pathway in the aging process (Kenyon 2010) . Likewise, a role for mitochondrial function in aging is suggested by the finding that impairments to mitochondrial function can extend lifespan in C. elegans and mice (Ewbank et al. 1997; Feng et al. 2001; Dillin et al. 2002; Lee et al. 2003; Liu et al. 2005; Hughes and Hekimi 2011; Wang and Hekimi 2015) .
Another point of view is provided by the study of mutations in a number of genes that induce segmental progeroid syndromes and shorten lifespan in mice. The short lifespan of these mutant mice is accompanied by the accelerated expression of some of the phenotypes commonly encountered in aging (Mounkes et al. 2003; Wong et al. 2003; Baker et al. 2004; Chang et al. 2004; Trifunovic et al. 2004) . While these have often been presented as representing alterations to the aging process, it remains possible that their shorter lifespans is caused by the induction of specific pathologies that only mimic aspects of the actual aging process (Harrison 1994; Miller 2004 ).
It has also been argued that an extension of lifespan may not necessarily be concrete evidence of a retardation of the aging process (Orr et al. 2003; De Magalhaes et al. 2005; Ladiges et al. 2009 ). In this view, a lifespan-extending intervention may simply remedy deficiencies in the environment or in the genetic make-up of one particular strain. The intervention would therefore extend lifespan by correcting specific flaws rather than altering the aging process. These considerations create a conundrum: if lifespan is not a reliable measure of aging, how can we confirm that a particular manipulation truly affects the aging process? One approach is to assess physiological phenotypes which are known to deteriorate with age, such as cognition or the functioning of the cardiovascular or immune systems, in order to detect similarities or discrepancies with the patterns observed in control strains. An alternative criterion is to consider whether a particular manipulation changes how mortality rates increase with age (Sacher 1977; De Magalhaes et al. 2005; Yen and Mobbs 2010) . This is based on the hypothesis that the increased incidence of the age-related pathological changes that characterizes the aging process is reflected in changing mortality rates.
Human mortality rates increase exponentially with age, as first noted and quantified by Benjamin Gompertz in 1825 (described by Olshansky and Carnes 1997) . This property has subsequently been observed for the mortality rates of model organisms including mice, Drosophila and C. elegans (Johnson 1987; Gavrilov and Gavrilova 1991; De Magalhaes et al. 2005 ). The Gompertz model of mortality is commonly expressed by the following equation, where the mortality rate (R) can be represented at any age (t) for a given population by:
R(t) = Ae
Gt 'G' describes the rate at which mortality rates accelerate with age and 'A' represents the initial mortality rate at time 0 . 'A' is strictly theoretical as a mortality rate, since there can be no actual mortality at time 0. Instead, it can be determined by extrapolation from mortality rates at greater ages, and does not necessarily correspond to true mortality rates at birth or during youth. Figure 1 shows how changes to the Gompertz parameters affect the survival curve of a hypothetical population of mice with a median lifespan of 2 years (in black). Decreasing 'A' (solid blue lines) extends lifespan by shifting the inflection point of the curve rightwards, such that it occurs proportionally later in age, relative to maximum lifespan. There is no change in the apparent "slope" of the curve. In contrast, decreasing 'G' (dashed blue line) decreases the slope.
'A' has been described as measuring the vulnerability to disease unrelated to the onset of aging (Sacher 1977) , or the effect of the environment on mortality ). Changes to 'A' will alter mortality rates evenly across the lifespan of the population. In contrast, since the parameter 'G' can be considered a rate constant for the age-related increase of mortality of a sample or population, it is often given a pre-eminent role as an indicator of the "rate of aging" (Sacher 1977; ). This is a logical hypothesis, since an increased or decreased 'G' would likely reflect the rate at which physiological conditions are declining with age. Therefore it is often assumed that interventions that extend lifespan by slowing aging, rather than by alleviating some age-independent pathology, will be associated with a decreased 'G'; likewise, those that accelerate aging would be associated with an increased 'G' (Takeda et al. 1981; Honda et al. 1993; Pletcher et al. 2000; De Magalhaes et al. 2005; Merry 2005; Yen et al. 2008; Tricoire and Rera 2015) . It should be noted, however, that some have argued against this viewpoint, and suggest that 'G' should not be assigned a dominant role as a measure of aging (Driver 2001; Masoro 2006) . Although the Gompertz model seems to fit survival curves for many human and model organisms, it can be modified to provide a better fit. It can include additional terms that account for mortality rates that plateau at later ages (logistic model), deaths due to exogenous, non-agingrelated environmental causes (Makeham model), or both (i.e., logistic-Makeham) (Wilson 1994 ).
Some caution is necessary, however, when interpreting survival curves that appear to be better fitted by more complex variants. For example, if the survival curve of a population is not optimally fitted by a particular model, then the addition of further parameters will naturally allow for more flexibility to adjust the model to the survival curve, without necessarily being informative about the underlying biology (Wilson 1994) . Furthermore, a population of 100 or more is necessary to reliably determine which model best fits a particular distribution (Wilson 1994) . Since most lifespan studies in mice use fewer animals than this, it is reasonable to use the simplest possible model in these cases, i.e. the Gompertz model. Using this model, some studies observed a decreased 'G' in cohorts of long-lived mice (Lapointe et al. 2009; Hughes and Hekimi 2011) . However, a recent analysis of 29 published lifespan studies found this to be relatively rare in mice subjected to lifespan-extending dietary or genetic manipulations (Yen et al. 2008) . Instead, it was changes in 'A', not 'G', that were most frequently observed, with 4 of 12 long-lived strains having a statistically significant increase in 'A', but only 1 of 12 having a decreased 'G'. Strikingly, the remainder did not exhibit any statistically significant changes in Gompertz parameters at all. Lifespan-shortening interventions were somewhat more likely to be associated with decreases in 'G', with 6 out of 15 short-lived strains associated with a statistically significantly decrease in 'G' and 5 with a decrease in 'A'. We theorized that actual changes in the parameters are being masked by the relatively small sample sizes that often characterize lifespan studies in mice, and that looking at individual studies by this method will fail to reveal systemic relationships between changes to lifespan and Gompertz parameters.
Since a substantial number of studies reporting changes in mouse lifespan resulting from genetic manipulations have now been published, we hypothesized that a correlation-based approach may be a more powerful technique to search for patterns in Gompertz parameter shifts.
For example, a negative correlation between lifespan and 'G' across long-lived lines of mice would suggest that their extended longevity was due to a decreased rate of aging.
Dramatic changes in mortality rate trajectories have been reported across different species (Jones et al. 2014) , demonstrating the importance of studying these phenomena in diverse model organisms. The nematode roundworm C. elegans has been used to identify many lifespan-extending and -shortening mutations. The strength of invertebrate model systems such as C. elegans for aging research is their short lifespan and the possibility to repeatedly carry out experiments with very large cohorts, as well as the possibility to identify mutants with very large increases in lifespan. Early studies with this organism established that C. elegans mortality patterns apparently followed the Gompertz model (Johnson 1990; Honda and Matsuo 1992; Vanfleteren et al. 1998) , with variations depending on growth conditions (Vanfleteren et al. 1998) . Later studies investigated whether the environment and mutations could alter Gompertz parameters in this organism (Lenaerts et al. 2007; Wu et al. 2009; Yen and Mobbs 2010) . We therefore elected to analyze short-and long-lived C. elegans as a comparator to our analysis of mice.
By the straightforward method of plotting Gompertz parameters against lifespan we found that most of the genetically-driven variability in lifespan between normal-or long-lived groups of mice was due to changes in 'A', not in 'G'. In fact, 'G' remained remarkably invariant for different groups of wild-type mice as well as for mice with genetic variations that extend lifespan. The only exceptions to this trend were some interventions which acutely shortened lifespan. We also found this to be true for a collection of inbred mice strains studied under uniform conditions as part of the Mouse Phenome Database at The Jackson Laboratory (Yuan et al. 2009 ). Thus, with the exception of some severe lifespan-shortening interventions, lifespan in laboratory mice is largely determined by factors that affect initial vulnerability, rather than agedependent mortality rate acceleration. In contrast to mice, we found lifespan to be associated with changes in 'G', not 'A', among long-lived C. elegans mutants. This was true as a trend across long-lived mutants, and was also observed by analysing changes to Gompertz parameters among numerous replicate studies of the well-characterized daf-2, isp-1, and eat-2 mutants.
MATERIALS AND METHODS

Estimation of Gompertz parameters
In order to estimate Gompertz parameters, numerical survival data was extracted from published Kaplan-Meier survival curves using Engauge Digitizer 6.2 (Mark Mitchell, http://markummitchell.github.io/engauge-digitizer/). Survival data was divided into 10-or 1-day intervals for mice and C. elegans respectively, and Gompertz parameters were determined by MLE using WinModest 1.0.2 (Pletcher 1999) , according to the Gompertz or logistics hazard functions (Pletcher et al. 2000) :
All estimates had associated inform values of '0', indicating that the maximum likelihood procedure was able to successfully resolve parameters within the given range, and that asymptotic confidence intervals could be calculated. For all groups, the accuracy of the estimation was graphically confirmed by overlaying the resulting Gompertz survival function on the raw survival data using Prism 6 (GraphPad Software, USA).
For C. elegans, initial analysis using the logistic model yielded a clear bimodal distribution of values across strains for the logistic parameter 'L', with clusters of value greater than 0.01 and lower than 1 x 10 5 . Parameters in this lower group were more difficult to determine by MLE, with many appearing to resolve to arbitrarily small values without resulting in further changes to 'A' or 'G'. We therefore set these values to 0.
Model Comparison
We used WinModest's likelihood theory-based tools to determine which model (among Gompertz, logistic, Makeham or logistic-Makeham) provided the best fit for C. elegans survival curves. This methodology takes into account the fact that models with additional parameters will naturally be less constrained when attempting to fit to a data set, and therefore identifies the mortality model with the fewest parameters that fits the data sufficiently. This method is therefore superior to simple comparison of correlation coefficients obtained by regression-based methods.
General statistics
Non-parametric Spearman correlation was used to quantify the relationship between lifespan and Gompertz parameters. Prism was used to determine Spearman correlation coefficients and perform significance tests. For all tests a p-value of less than 0.05 was taken to indicate statistical significance.
For pair-wise comparisons between values of mutant and control parameters, differences (mutant -control) were used rather than ratios because of the presence of negative or extremely low values. The non-parametric Wilcoxon signed rank test was used to determine whether the average effect size was significantly different from 0. As an additional method of investigating the role of Gompertz parameters in alterations to lifespan, we used WinModest's longevity decomposition tool to determine the extent to which the differences in Gompertz parameters between control and mutant groups contributed to changes in lifespan (Pletcher et al. 2000) .
VBA Code used to generate the simulated data described in supplemental figures is provided in File S2, as a macro-enabled workbook for Microsoft Excel 2010.
RESULTS
Lifespan of normal or genetically-modified long-lived mice is largely determined by changes to 'A', not 'G'
In order to calculate Gompertz parameters, one requires numerical survival data beyond what is typically provided in published reports. Gompertz parameters for a number of short-and longlived strains have previously been determined (Yen et al. 2008) , and we included those in our analysis (Set 1, summarized in Table S1 . Note that we did not include calorically restricted groups in our analysis). We divided the mice into groups based on their lifespans. Short-lived mice were defined as those subjected to genetic manipulations that shortened lifespan relative to controls. We also included in this group lines of mice known to have average lifespans markedly shorter than conventional lines of laboratory mice, namely NZB/W mice, which are known to suffer from severe autoimmune disease (Partridge et al. 2005) , and Senescence Accelerated Mice (SAM) as well as their "Senescence Resistant" (SRM) controls (Avraam et al. 2013) . Normallived mice were defined as those of the control strains, with lifespans typical of laboratory mice strains. Median "normal" lifespans varied considerably (from 550 to 960 days), presumably dependent upon genetic background or husbandry. Lines of mice were defined as long-lived if their lifespan was extended relative to normal-lived controls.
This compilation was published in 2008, and the increasing ease of mouse genetic manipulations and continued interest in understanding the causes of aging has meant that the number of long-lived strains has continued to grow. We therefore obtained numerical survival data from the published survival curves of an additional 32 separate studies comparing 31 separate long-lived mutants (Set 2, summarized in Table 1 ). We did not search for additional short-lived strains of mice.
The two sets together therefore encompass a diverse collection of genetic manipulations that have been shown to extend lifespan, and likely comprise a majority of published reports of long-lived strains of mice (Yuan et al. 2009; Liao and Kennedy 2014) . The affected genes include those playing a role in oxidative stress response, signaling (mTOR, insulin/insulin-like or growth hormone), metabolism, genomic integrity, mitochondrial function and cellular proliferation. One strain of mice, Atg5 transgenics, (Pyo et al. 2013) , were excluded from further analysis because the parameter estimates ('G' of 8 to 14, and a ln(A) of -14 to -25) were so markedly different from the remainder of the strains (Table 1) .
To determine if either Gompertz parameter changed systematically with changes in longevity, we examined the relationship between median lifespans and Gompertz parameters for Estimation of Gompertz parameters can be subject to biases resulting in systematic under-or over-estimations (Promislow et al. 1999) , especially for smaller samples sizes, potentially introducing statistical artifacts into our analysis. Correction for potential systematic biases in parameter estimations (determined using standard resampling techniques), as well as removal of possible outliers, did not change the effects described above (see Figure S4 and its legend).
Genetic differences underlie the relationship between 'A' and lifespan in a panel of inbred mice
The results shown in Figure 2 imply that the biological mechanisms that determine lifespan in laboratory mice are largely those associated with changes to 'A', rather than 'G'. As described above, 'A' has been interpreted as representing the effect of age-independent factors on lifespan.
It is therefore possible that the systematic decrease in 'A' with increased lifespan that is apparent in Figure 2 could be due to environmental differences between studies, with more beneficial environments resulting in decreased aging-independent mortality rates and, consequently, longer lifespans. Indeed, differences in the quality of husbandry have been raised as a potential confounding variable in aging studies (Liang et al. 2003; Ladiges et al. 2009 ).
To address this question, we conducted a pair-wise comparison, within studies, of The above analysis considers 'A' and 'G' separately, when, in reality, changes in both parameters cooperate to establish a new survival trajectory when the survival curve of a population is shifted. It is possible to determine the contribution of each parameter to changes in average longevity (longevity decomposition), revealing the extent to which each parameter is responsible for the shift in lifespan (Pletcher et al. 2000) . Thus, among the long-lived strains of Set 2, changes to 'A' account for the majority of the lifespan increase in 38 out of 52 long-lived strains ( Figure 3B ; p = 0.0009 vs. expected by chance, by Chi-square test).
To further differentiate between environmental and genetic effects we determined the relationship between the Gompertz parameters and lifespan among a group of 31 inbred strains of mice of various average lifespans that were maintained under uniform conditions. Complete survival data was obtained from the Mouse Phenome Database, maintained by The Jackson
Laboratory (Bogue et al. 2016) . The 31 inbred strains used in this study were selected to encompass the greatest possible genetic diversity (Yuan et al. 2009; Yuan et al. 2012 ) and included wild-derived strains as well as representatives from the seven genetically-related groups that comprise laboratory mice (Yuan et al. 2009 ).
In this dataset ( Figure 4 , Table S2 ), there was no correlation between median lifespan and 'G' (r = 0.16, p = 0.23), but lifespan was correlated with ln(A) (r = -0.58, p < 0.0001). These relationships were unchanged when we corrected for systematic bias in parameter estimations, as well as upon removal of possible outliers ( Figure S5 ).
As an additional test, we determined the relationship between the Gompertz parameters and lifespan among a group of 44 recombinant inbred strains of mice of various average lifespans that were maintained under uniform conditions (males and females analyzed separately) (Liao et al. 2010) . Although the low sample size of these groups (n = 5) limits the reliability of Gompertz parameter estimation, we still observed the same pattern of relationships between Gompertz parameters and lifespan, with no correlation between 'G' and lifespan (r = 0.14, p = 0.2) and a negative correlation between ln(A) and lifespan (r = -0.38, p = 0.0006) ( Figure S6 , Table S3 ).
Lifespan in C. elegans mutants is associated with changes to 'G', not 'A'
We wondered whether other classic model organisms commonly used for aging research would demonstrate a similar invariance for 'G' with increased lifespan. The nematode C. elegans is one of the most widely-used model organisms for the study of aging (Antebi 2007; Li and Ren 2007; Van Raamsdonk and Hekimi 2010) . We calculated Gompertz parameters from published survival curves of 39 long-lived and 8 short-lived mutants, along with the 20 associated wildtype (N2) controls (Table 2 ). These mutants were chosen to affect a diverse collection of biological pathways including, but not limited to, mitochondrial function, insulin/insulin-like signalling, nutrient uptake, stress resistance, sensory perception and autophagy. All lifespan experiments were carried out at 20 o on agar plates, and had an associated N2 control. Because of the large number of long-lived worm mutants that have been identified, this represents only a limited subset of potentially usable strains. For comparison, the GenAge database of agingrelated genes (Tacutu et al. 2013 ) currently lists 112 long-lived C. elegans mutants (although survival experiments for these mutants were not all conducted in a manner that would have satisfied our inclusion criteria).
Initial observations showed that the standard Gompertz model poorly fitted the survival of many groups of worms. In line with this, an automated lifespan analysis performed on populations of C elegans with very large sample sizes (> 200 animals) has recently shown that the exponential increase in mortality rates that characterize the Gompertz survival model largely ceases at later ages (Stroustrup et al. 2016) . Thus, logistic models that account for late-life mortality rate de-acceleration provide a better fit for C. elegans survival data. Indeed, of the 11 groups of N2 worms with n > 100 (at which sample size the actual population model can be reliably determined from the sample (Wilson 1994 Within studies, pair-wise comparisons between mutant and N2 control worms reveal that 'G' is increased, and that changes to 'G' makes the greatest contribution to the increase in average lifespan, for 6 out of 7 short-lived strains ( Figure 6A Figure 6C ). Accordingly, changes to 'G' made the greatest contribution to the increased average lifespan in 33 out of 39 long-lived strains ( Figure 6D ).
Due to the inherent variability in any one study, it would be difficult to reliably conclude whether a particular long-lived strain has a certain characteristic effect on the Gompertz parameters. For example, unique environmental or methodological issues could subtly influence the pattern of mortality in a particular study. We therefore analyzed survival results from multiple studies for three long-lived mutants which have been widely studied. We chose daf-2(e1370) as a model of impaired insulin/insulin-like signalling (Kenyon et al. 1993; Murphy and Hu 2013), isp-1(qm150) as a model of impaired mitochondrial function (Feng et al. 2001; Dancy et al. 2015; Wang and Hekimi 2015) , and the feeding-impaired eat-2(ad1116) mutant as a model of caloric restriction (Lakowski and Hekimi 1998; Lan et al. 2015) . We identified 18 daf-2 studies, 13 isp-1 studies, and 23 eat-2 studies, and determined the Gompertz parameters from published survival data (Table S4) were the dominant contributor to the increased average lifespan ( Figure 7D-F) . We therefore conclude that daf-2, isp-1 and eat-2 mutations can be reliably said to extend lifespan through decreases to the age-dependent acceleration of mortality rates.
DISCUSSION
We found that the age-dependent acceleration of mortality rate, 'G', remained essentially invariant throughout the wide range of lifespans that characterized normal and genetically longlived mice (Figure 2 ). This is consistent with earlier findings that 'G' is reasonably constant between different human populations and among a small number of inbred strains of laboratory mice , as well as among wild-caught strains of Drosophila (Spencer and Promislow 2005) , and that lifespan-extending interventions in mice had a tendency to be associated with statistically significant changes in 'A', rather than 'G' (Yen et al. 2008) . We have shown that this effect is systematic, rather than sporadic, and can be observed even in homogenous environmental conditions, where the genetic makeup of the strains is the only variable ( Figure 4) .
Thus it appears that most variation in mouse lifespan -save for extreme shortenings -is largely due to mechanisms that impact initial vulnerability. Importantly, this is true among populations of both wild-type control strains and those with experimentally-introduced or spontaneous single-gene mutations that extend lifespan.
The apparent invariance of 'G' for mice (Figure 2 and 4) suggests that it is fixed within a relatively narrow band, with both increases and decreases likely to be associated with dramatically shortened lifespans. Indeed, for the data set containing short-lived mice, the three lowest 'G' values, as well as the seven largest, were associated with shortened lifespans (Table   S1 ; Figure 2A Table S1 ) exhibit some marked physiological deficiencies in addition to their dwarf stature, including infertility, decreased ambulatory activity, and early frailty exemplified by a requirement for a prolonged nursing period and group housing (Conover and Bale 2007) , along with a trend towards an increased 'A'. Thus, observations in these two strains are consistent with decreases to 'G' in mice being associated with detrimental effects of varying severity. These may be counter-balanced by protective effects over the long term resulting in an increased lifespan.
Short-lived lines of mice demonstrated great variability in terms of the relationship
between the Gompertz parameters and lifespan ( Figure 2 ). This is consistent with the view that some or all of these lines may be short-lived due to sicknesses distinct from aging, and that the diversity of possible causes of mortality in this group combine to prevent the establishment of any clear pattern.
The remarkable invariance of 'G' across a great range of mouse lifespans would imply that these differences in lifespan do not reflect changes to the underlying biological aging process. This would seem to suggest that the vast majority of variation to lifespan seen in normal or long-lived mice -whether due to single-gene mutations or the more complex genetic heterogeneity among different strains -is not associated with any change in the aging process, but rather to aging-independent physiological features. Thus, Bub1b mutants (G = 2.55; median lifespan = 6 months), C57Bl/6 controls for Trx transgenic mice (G = 2.67; lifespan = 19 months)
and Prop1 df/df mice (G = 2.89; lifespan = 41 months) could be said to be aging at essentially the same rate. This is a surprising finding, since several long-lived strains of mice have been found to be resistant to the development of age-dependent pathologies (Flurkey et al. 2001 exhibited superior maintenance of motor skills and immune function into old age relative to their wild-type controls (Selman et al. 2008; Selman et al. 2009 ). Such signs of delayed biological aging have also been observed in FIRKO (Katic et al. 2007 ) and αMUPA (Gutman et al. 2011; Yanai et al. 2011) mice, both of which were found to be long-lived with a statistically significant decrease in 'A' and a trend towards an increased 'G' (Table S1 ).
It would seem surprising that a population that isn't aging slower would consist of individuals showing a slower rate of biological aging. How can we explain long-lived mice with fewer age-dependent pathologies but an unchanged rate of population aging? One possible explanation for this apparent paradox is that these interventions are delaying the age of onset of age-related pathologies, rather than slowing their progression. Pathological analysis carried out at a single young and old age (represented by the vertical dashed lines in Figure 1 ), as is common in murine lifespan studies, would not differentiate between delays in pathology onset and a change in the rate at which they worsen. Interestingly, a delayed onset of age-related pathology would also mirror the changes to mortality patterns for populations where lifespan increases due to changes to 'A', in which the rapid increase in mortality rates that characterizes mid-to-old age animals is delayed (Fig 1, solid blue lines) . It has also been suggested that such a 'rectangularization of the survival curve' in human populations would be associated with decreased durations of morbidity and hence beneficial (Fries 1980) .
It is also worth noting that, although the theory behind the Gompertz model has been well explored (Gavrilov and Gavrilova 2001; Ricklefs and Scheuerlein 2002; Eugene M.G 2008) , the role of 'G' as a measure of the "rate of aging" does not seem to have been subject to experimental validation (Driver 2001; Masoro 2006) . As an alternative to the traditional view of 'G' as a measure of aging, it has been suggested that a reduction in age-specific mortality throughout most of adult life would be sufficient evidence of a slower rate of aging, even if the rate at which it increased with age was unaffected (Masoro 2006) . If future studies were to find that long-lived lines of mice display convincing evidence of a slower rate of accumulation of age-dependent pathology (i.e., slower biological aging), despite alterations to 'A' rather than 'G', this may be cause to re-think our conventional understanding of the meaning behind the Gompertz parameters.
The extended lifespans of long-lived C. elegans mutants were found to be associated with decreases in the Gompertz parameter 'G', the rate of aging. This is in striking contrast to what we observed in mice. Such species-specific differences should perhaps not be unexpected: although C. elegans has important advantages as a model organism for the study of aging, they are (unlike mammals) poikilothermic and self-fertilizing hermaphrodites (Brenner 1974; Hekimi et al. 2001) , and aspects of their aging process are clearly distinct from those of mammals (Gruber et al. 2014) . For example, the last portion of worm lifespan is often spent lying immobile on their plate, only moving rarely or if prodded (in some long-lived mutants, they can spend ¼ of their life in this state) . This is not observed in mice, where immobility is cause for immediate euthanasia. Nematodes are also tolerant of physiological states that would be lethal in mammals, such as extreme hypoxia and hyperoxia (Van Voorhies and Ward 2000) .
Another striking difference between long-lived worm and mouse mutants is the degree to which lifespan can be extended. Among the studies analyzed here, the average percent increase in lifespan was 76 % for worms (with a maximum of 250 % for daf-2(e1370) mutants and eight other strains with greater than a 100 % increase) versus 20 % for mice (including Sets 1 and 2).
Among mice, the two strains showing the greatest increase in lifespan showed increases of 92 % and 51 % respectively, substantially less than observed for long-lived C. elegans ( Figure S8A ). It is possible that dramatic physiological shifts are required for the greatest increases in lifespan, and that these are associated with changes to 'G' rather than 'A'. Thus we could predict that longlived strains of C. elegans or mice with equivalent increases in lifespan relative to their controls might show similar changes to their Gompertz parameters. This is difficult to test because of the limited overlap in the degree of lifespan extension between the two species ( Figure S8B ).
However, at the point of greatest overlap (C. elegans and mice with median lifespans extended between 1.3 -1.4 times relative to their controls), while there does not appear to be a difference in the effects on 'G', the effects on ln(A) are significantly different between the two species (p = 0.0317 by Mann Whitney test, with ln(A) tending to be increased in long-lived worms and decreased in long-lived mice). This suggests that the inter-species difference in parameter effects is not simply due to the degree of lifespan extension.
The trends that we have described in this study do not rule out the existence of long-lived mouse mutants with decreases in 'G' rather than 'A', or long-lived worms with changes to 'A' rather than 'G'. Such exceptions would in fact be valuable comparators to lines showing the more stereotyped pattern of changes, and may help relate changes in mortality trends to underlying biological mechanisms. Interestingly, one environmental intervention, caloric restriction, seems to increase lifespan in mice via decreases to 'G', rather than 'A' (Simons et al. 2013) .
C. elegans, in particular, are an attractive model organism for identification of short-or long-lived strains that exhibit atypical Gompertzian behavior because their short lifespan and minimal requirements for uptake allow for higher throughput lifespan experiments with greater sample sizes. Indeed, a recent study used a novel automated imaging system to collect high precision survival data for multiple replicate populations of 500 or more animals (Stroustrup et al. 2016) . Intriguingly, they found that lifespan shortening or extending mutations resulted in survival curves that could be mapped onto control survival curves by application of a single temporal scaling parameter. The mortality rate models used here were constructed using a parameterization that is incompatible with such investigations of temporal scaling (Stroustrup et al. 2016 ), but it is tempting to imagine using this tool to identify strains of C. elegans that have extended lifespans characterized by decreases to 'A', rather than 'G'.
In conclusion, our principal finding is the interspecies variation in mortality rate kinetics in response to genetically driven changes to lifespan. In normal and long-lived mutant mice, there was a remarkable invariance of the age-dependent acceleration of mortality rate, as represented by the Gompertz parameter 'G', across a wide range of median lifespans. Although genetic manipulations are capable of increasing 'G' in mice, such changes are more likely to result in shortened than in lengthened lifespan. Genetic alterations that extend lifespan, or affect lifespan within the normal range, almost invariably act through changes to the age-independent Gompertz parameter 'A'. This appears to be true for single-gene mutations, as well as for the more complex changes that affect lifespan in various laboratory strains. This indicates that the vast majority of mouse lifespan extensions achieved via genetic manipulation are due to a delay in the onset of age-dependent mortality, rather than a slowing of the aging rate itself. This was not, however, conserved across species, with long-lived C. elegans exhibiting a decreased 'G'. It is perhaps not surprising that the nature of lifespan extension may be fundamentally different between these species, given the substantial differences in physiology and environmental niche occupied, as well as lifespans that differ by orders of magnitude. Vertical dashed lines show typical ages used for assessment of changes to age-dependent pathologies in mice. Laboratories (see Table S2 for Note that some mutant strains were compared to the same N2 * sum of at least 3 independent trials and an initial number of 80 worms per strain per trial ** Twenty worms per plate were examined with three trials per strain 
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